logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Pfizer Tops Estimates in Second Quarter, Reiterates Full Year Outlook

By  +Follow July 30, 2013 8:52AM
Share:
Tickers Mentioned:

Pfizer Inc. (PFE) , the biggest drugmaker in the world, on Tuesday reported second-quarter earnings that nipped past analyst predictions as the company fought through declining sales that were hamstringed by the loss of exclusivity on the blockbuster cholesterol fighter Lipitor.

For the quarter, NYC-based Pfizer said it generated $12.97 billion in revenue, compared to $13.97 billion in the second quarter last year.  Net income soared to $14.1 billion, or $1.98 per share, versus $3.25 billion, or 43 cents per share, in last year’s quarter.  In February, Pfizer spun-out its animal health business into a new company called Zoetis, Inc. (ZTS) .  In December 2012, it sold its nutrition business to Nestle SA ($NSRGY) for $11.85 billion, accounting for most of the surge in reported income.  Excluding gains from the sale, restructuring costs and other special items, adjusted profits for the second quarter totaled $4.0 billion, or 56 cents per share, compared to $4.45 billion, or 59 cents per share, in the year prior quarter.

Wall Street was expecting EPS of 55 cents on revenue of $13.01 billion.

Sales of Lipitor sank 55 percent from $1.22 billion in the second quarter of 2012 to $545 million in the latest quarter.  Sales of pneumococcal vaccine Prevnar slipped 3 percent to $969 million due to changes in government purchasing patterns.  Counterbalancing those losses, sales of Pfizer’s biggest drug Lyrica, which is indicated for fibromyalgia, diabetic nerve pain and more, improved by 10 percent to $1.13 billion.

Revenue for Pfizer’s leading business units – primary care, specialty care, emerging markets and established products – all declined compared to the year prior quarter.  Ian Read, chairman and chief executive at Pfizer, said in today’s statement that he expects emerging market business growth to accelerate in the second of the year, led by China.

“From a total company view, we are tracking to our expectations for the full year and continue to capitalize on the investments we are making to better position Pfizer for long-term success,” added Read.

The company backed its 2013 forecast of adjusted earnings in the range of $2.10 to $2.20 per share.

Sales of anti-cancer drugs rose 24 percent to $399 million, boosted in part by a 191-percent climb in sales of Xalkori to $67 million and $17 million in sales from new drug Inlyta.

Operating margin improved significantly from 29.9 percent to 41.3 percent.

Marking “the next step in Pfizer’s journey to further revitalize [its] innovative core,” Pfizer said on Monday that it intends to split its company into three new units.  One unit will focus on drugs that are patent-protected beyond 2015.  The second will include vaccines, oncology and consumer healthcare products.  The third will include drugs that have lost – or will soon lose – patent exclusivity, generics and future product collaborations.  The changes are slated to start happening in January.

Two new drugs, blood thinner Eliquis and rheumatoid arthritis drug Xeljanz, are thought by many to have the capabilities to grow into blockbusters, although Zeljanz is facing some hurdles in Europe with negative opinions being offered by a European Medicines Agency committee.  Zeljanz generated $33 million in sales in the second quarter. The FDA is reviewing a supplemental New Drug Application (NDA) for Zeljanz with a decision expected by February.  Topline results are expected from two ongoing phase 3 trials evaluating Zeljanz in the second quarter next year.  The FDA is also reviewing a supplemental NDA for Eliquis, with a decision expected by March 15, 2014. 

During the second quarter, Pfizer repurchased $3.3 billion worth of its common stock, bringing its first-half total to $8.7 billion.

Shares of PFE have risen 20 percent so far in 2013 through Monday’s close at $29.54.  

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for PFE
Rosner Stocks
1 Oct 14 01:48:31
$SEEK Market Cap Click Here: http://t.co/pmQtbHboPz Also See: $PFE $SLW $TASR $AMZN ~
Evener Investment
1 Oct 14 00:25:38
RT @SeekingAlpha: With Ebola Looming, When Will The Defense Department Get Around To Generex? http://t.co/wWbSwWNw5v $MNKD $PFE $GNBT
Quantpost Healthcare
1 Oct 14 00:22:08
$PFE News Alert: http://t.co/TvRp5q8piU Updated options view: https://t.co/g4ldpcdRM7 All options views: https://t.co/fArdRSxADp
Seeking Alpha
1 Oct 14 00:22:07
With Ebola Looming, When Will The Defense Department Get Around To Generex? http://t.co/wWbSwWNw5v $MNKD $PFE $GNBT
Investors Hangout
1 Oct 14 00:08:55
$NTEK Last Price Click Here: http://t.co/oc2jYl6U4U Also See: $UAMM $PFE $BNS.TO $IBB ~
Investors Hangout
30 Sep 14 22:37:44
$MHYS Yield Click Here: http://t.co/e8OdMwwUG1 Also See: $SPEX $PFE $MYEC $F ~
Future Tech Investor
30 Sep 14 20:02:39
$NVAX #Ebola play? Research it $BRCX $GNVC $PFE $NNVC $AZN $F $GPRO $MBLY $WB $JD $TSLA $PLUG $BLDP $KNDI $ACHN $AGEN $SSYS $GE $YHOO $GSK
Rosner Stocks
30 Sep 14 19:18:35
Rosner: PFE Pfizer, Inc. $PFE Company Overview Stock http://t.co/0cNe6pQiHB
iHangout
30 Sep 14 19:15:43
http://t.co/jYcEVtZYAh Rosner: Stock Info: PFE Pfizer, Inc. $PFE Company Overview Stock http://t.co/JCrQZSIESi
Rosner Stocks
30 Sep 14 19:14:46
PFE Pfizer, Inc. $PFE Company Overview Stock Message Board Recent Posts http://t.co/8FdiNx3GTP http://t.co/ozuZb1BLZs
Stock_Tracker
30 Sep 14 18:34:58
Pfizer Inc (PFE) 29.57 $PFE Most active New York Stock Exchange-traded stocks AP - Tue Sep 30, 5:04PM CDT NEW http://t.co/ZwxdDKEpPa
chartguy89
30 Sep 14 18:33:20
PFE 29.57 Stock Charts $PFE Pfizer Inc. (NYSE) Last Updated: 09/30/2014 20:33:17 PFE Stock Chart - 1 Month htt http://t.co/wmiTVOTO23
Stock Wire
30 Sep 14 18:14:53
Drugmaker Pfizer, aiming to raise sales of its Viagra, starts new ad campaign ... $PFE http://t.co/bQ1rPPnpO6
Stock Wire
30 Sep 14 16:35:35
Stocks Alert: Pfizer Inc. (NYSE:PFE), Angie's List Inc (NASDAQ:ANGI), Oncomed ... $PFE http://t.co/bbSNGg6ODh
crhz1978
30 Sep 14 16:27:25
$HEB surging over 40% after hours as company working with US Army on a cure!!! $pfe $jnj $dndn $ctic $GSK #Ebola $aapl $mrk #cnbc #news
crhz1978
30 Sep 14 16:16:39
$HEB surging 40% after hours as company working with US Army on a cure!!! $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news
crhz1978
30 Sep 14 15:30:43
$HEB surging 30% after hours as company working with US Army on a cure!!! $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news
crhz1978
30 Sep 14 15:29:35
$HEB surging 30% after hours as US confirms case inside country! $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news
crhz1978
30 Sep 14 14:58:51
$HEB surging 25% after hours as US confirms case inside country! $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news
$Stocknewsalerts
30 Sep 14 14:31:02
$PFE ALERT: New Pfizer SEC Filing From our Stock News Alerts App
crhz1978
30 Sep 14 14:16:48
$HEB surging 25% - company working with US Army on cure!!!!!! $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news
crhz1978
30 Sep 14 14:12:07
$HEB surging 25% after hours. Company likely has cure for #ebola? Working with US #army $pfe $jnj $ctic $kerx $GSK #Ebola $aapl $mrk #news
crhz1978
30 Sep 14 14:07:00
$HEB surging 40% after hours as US confirms case inside country. $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news
crhz1978
30 Sep 14 14:06:38
$HEB surging 25% after hours as US confirms case inside country. $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news
crhz1978
30 Sep 14 14:03:50
$HEB surging 20% after hours as US confirms case inside country. $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news
Henry E. Chang
30 Sep 14 14:02:54
Drug #Patents Held Overseas Can Pare Makers’ Tax Bills → http://t.co/Fmp8M9eOw1 @nytimes $GILD $PFE $ABBV $ACT $MYL $ALXN $REGN $BMRN $CELG
crhz1978
30 Sep 14 14:02:45
$HEB surging as US confirms first case inside country. $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $mrk #cnbc #news #BreakingNews
$Stocknewsalerts
30 Sep 14 14:01:06
$PFE ALERT: New Pfizer SEC Filing From our Stock News Alerts App
jjz
30 Sep 14 13:43:48
RT @pharmalot: Pfizer TV ads for Viagra are targeting women. The message: women also suffer from erectile dysfunction. http://t.co/fvKhX71x…
12Stocks.com Biotech
30 Sep 14 13:39:39
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study.. http://t.co/NR3pqDone2 $PFE #biotech #stocks
12Stocks.com Biotech
30 Sep 14 13:39:22
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study.. http://t.co/goXNCxpLKN $PFE #biotech #stocks
12Stocks.com Biotech
30 Sep 14 13:39:04
1:16 am Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination study.. http://t.co/54qxMBMgcL $PFE #biotech #stocks
12Stocks.com Biotech
30 Sep 14 13:38:43
[video] Viagra's New Ad Campaign to Target Women for First Time.. http://t.co/WSZillKH8k $PFE #biotech #stocks
12Stocks.com Biotech
30 Sep 14 13:38:25
Viagra ads target women for 1st time.. http://t.co/sut4gSP0Hp $PFE #biotech #stocks
12Stocks.com
30 Sep 14 12:58:43
Dow #Stocks Trend $NKE $MCD $KO $BA $CSCO $T $HD $VZ $INTC $AXP $PFE $DD $TRV $UTX $DIS $MSFT $JNJ $PG $UNH $WMT @ http://t.co/TvzJfd0RGT
$Stocknewsalerts
30 Sep 14 12:33:06
$PFE ALERT: New Pfizer SEC Filing From our Stock News Alerts App
$Stocknewsalerts
30 Sep 14 12:07:05
$PFE ALERT: New Pfizer SEC Filing From our Stock News Alerts App
NASDAQ
30 Sep 14 11:36:01
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/d6iL5JWaRP
NASDAQ
30 Sep 14 11:36:00
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/hXtDlsFD9x
NASDAQ
30 Sep 14 11:35:58
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/eF6AouPNiK
NASDAQ
30 Sep 14 11:35:56
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/HchirgMRrZ
NASDAQ
30 Sep 14 11:35:55
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/SHoadndK7y
StockNews
30 Sep 14 11:35:44
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/EAurxvumOh
StockNews
30 Sep 14 11:35:43
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/desWzj51EW
StockNews
30 Sep 14 11:35:41
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/zQHMNTq2cW
StockNews
30 Sep 14 11:35:39
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/AI8Lg5p2aD
StockNews
30 Sep 14 11:35:38
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/O6uU5J0I4h
Solo traders
30 Sep 14 11:35:31
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/MxWlY3MnLE
Solo traders
30 Sep 14 11:35:29
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/c4tNAjcJ0k
Solo traders
30 Sep 14 11:35:28
$PFE - Statement of Changes in Beneficial Ownership (4) http://t.co/OrdpX26MXn
				
				
By  +Follow July 30, 2013 8:52AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.